more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

Industry: NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

PerkinElmer (PKI) to Post Q3 Earnings: What's in the Cards?

by Zacks Equity Research Published on October 26,2021

PerkinElmer's (PKI) third-quarter results are likely to reflect strong performance at the Diagnostics segment.

MaxLinear (MXL) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research Published on October 25,2021

MaxLinear's (MXL) third-quarter 2021 results are expected to reflect gains from strength across the product portfolio and the broadband data access.

AXT (AXTI) to Announce Q3 Earnings: What's in the Cards?

by Zacks Equity Research Published on October 25,2021

AXT's (AXTI) third-quarter 2021 results are likely to show gains from increasing demand in indium phosphide and gallium arsenide substrates as well as the growing raw material business.

Nielsen (NLSN) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research Published on October 25,2021

Nielsen's (NLSN) third-quarter 2021 results are likely to reflect strength across Audience Measurement, Audience Outcomes and Gracenote Content Services.

tech-stocks

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research Published on October 22,2021

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

PKIPositive Net Change

PerkinElmer (PKI) Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research Published on October 22,2021

PerkinElmer (PKI) has been struggling lately, but the selling pressure may be coming to an end soon.

PKIPositive Net Change

medical

Will PerkinElmer (PKI) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research Published on October 21,2021

PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

PKIPositive Net Change

PKI or MTD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research Published on October 21,2021

PKI vs. MTD: Which Stock Is the Better Value Option?

Looking for Earnings Beat? Play These 5 Stocks

by Sanghamitra Saha Published on October 21,2021

Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.

earnings

PerkinElmer's (PKI) New Deal to Improve Single-Cell Profiling

by Zacks Equity Research Published on October 19,2021

PerkinElmer (PKI) partners with Honeycomb Biotechnologies to launch HIVE scRNAseq Solution, which can advance single-cell profiling.

PerkinElmer (PKI) Receives EUA from FDA for Latest Assay

by Zacks Equity Research Published on October 15,2021

PerkinElmer's (PKI) latest test receives EUA from the FDA, thereby enabling qualified laboratories to detect and differentiate SARS-CoV-2, influenza A, influenza B and RSV.

medical-devices

BD's (BDX) New Manufacturing Facility to Boost Supply Readiness

by Zacks Equity Research Published on October 15,2021

BD's (BDX) latest manufacturing line is expected to not only boost supply capacity but also provide priority access to needles and syringes to the U.S. government.

medical-devices

BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance

by Zacks Equity Research Published on October 14,2021

BD's (BDX) Rotarex Atherectomy System receives expanded 510 (k) clearance from the FDA that can help in the treatment of in-stent restenosis in the United States.

medical-devices

PerkinElmer's (PKI) Arm Gets FDA EUA Nod for Latest Assay

by Zacks Equity Research Published on October 13,2021

PerkinElmer's (PKI) unit receives FDA's EUA nod for its Anti-SARS-CoV-2 S1 Curve ELISA (IgG) that could aid in future understanding and provide insights on immune responses to SARS-CoV-2.

medical-devices

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

by Zacks Equity Research Published on October 12,2021

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Waters Corp

by Zacks Equity Research Published on October 05,2021

Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Waters Corp

industrial-products

3 Stocks to Watch on Rising Demand for Scientific Instruments

by Aniruddha Ganguly Published on October 04,2021

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters Corporation (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand as well as rising healthcare spending.